Health
Researchers develop α-emitting cancer therapy using a novel drug targeting LAT1 – News-Medical.Net
A cancer-specific L-type amino acid transporter 1 (LAT1) is highly expressed in cancer tissues.
A cancer-specific L-type amino acid transporter 1 (LAT1) is highly expressed in cancer tissues. Inhibiting the function of LAT1 has been known to have anti-tumor effects, but there has been limited progress in the development of radionuclide therapy agents targeting LAT1. Now, a multidisciplinary research team at Osaka University has established a targeted alpha-therapy with a novel drug targeting LAT1.
The researchers first produced the alpha-ray emitter 211Astatine, no easy task given that Astatine…
-
General23 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
Noosa News17 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News16 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
General21 hours agoNew Zealand wants more ‘automated decision-making’ in its welfare system. Could that lead to Robodebt 2.0?